ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,970.84
-1.11%
Dow Jones
42,992.21
-0.77%
US Dollar vs MXN
20.3272
0.00%
Brent Oil
73.44
0.00%
Bitcoin
94,443.16
0.30%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Dyne Therapeutics Inc (DYN) Cotización

Dyne Therapeutics Inc

Dyne Therapeutics Inc (DYN)

NASDAQ
23.72
-0.75
(-3.06%)
Cerrado 27 Diciembre 3:00PM
Delayed by 15 minutes
23.72
0.01
(0.04%)
Fuera de horario: 4:44PM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
23.72
Postura de Compra
23.72
Postura de Venta
26.61
Volume Operado de la Acción
683,735
23.40 Rango del Día 24.88
12.33 Rango de 52 semanas 47.45
Capitalización de Mercado [m]
2.414B
Precio Anterior
24.47
Precio de Apertura
24.20
Hora
437
@
23.72
(formt)
Última hora de negociación
Volumen financiero
US$ 16,413,783
Precio Promedio Ponderado
24.0061
Volumen promedio (3 m)
900,388
Acciones en circulación
101,765,958
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-10.23
Beneficio por acción (BPA)
-2.32
turnover
-
Beneficio neto
-235.94M

Acerca de Dyne Therapeutics Inc

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.dyne-tx.com
Sede
Wilmington, Delaware, USA
Fundado
-
Dyne Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DYN. The last closing price for Dyne Therapeutics was US$24.47. Over the last year, Dyne Therapeutics shares have traded in a share price range of US$ 12.33 to US$ 47.45.

Dyne Therapeutics currently has 101,765,958 shares in issue. The market capitalisation of Dyne Therapeutics is US$2.49 billion. Dyne Therapeutics has a price to earnings ratio (PE ratio) of -10.23.

DYN Últimas noticias

Más noticias

Form 4 - Statement of changes in beneficial ownership of securities

11 Diciembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

11 Diciembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Diciembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

06 Diciembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

06 Diciembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

06 Diciembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

04 Diciembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

25 Noviembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

22 Noviembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 Noviembre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.11-0.46160302140223.8324.923.3164488724.0370519CS
4-7.125-23.099367806830.84531.2923.3174994926.65979246CS
12-10.28-30.23529411763435.923.3190038829.75284201CS
26-10.28-30.23529411763447.4523.31111351434.8082287CS
5210.9585.747846515312.7747.4512.33140752828.26681025CS
15610.8684.447900466612.8647.454.370615422.38502052CS
2600.271.1513859275123.4547.454.357997821.81484544CS

DYN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Dyne Therapeutics?
El precio actual de las acciones de Dyne Therapeutics es US$ 23.72
¿Cuántas acciones de Dyne Therapeutics están en circulación?
Dyne Therapeutics tiene 101,765,958 acciones en circulación
¿Cuál es la capitalización de mercado de Dyne Therapeutics?
La capitalización de mercado de Dyne Therapeutics es USD 2.49B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Dyne Therapeutics?
Dyne Therapeutics ha negociado en un rango de US$ 12.33 a US$ 47.45 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Dyne Therapeutics?
El ratio precio/beneficio de Dyne Therapeutics es -10.23
¿Cuál es la moneda de reporte de Dyne Therapeutics?
Dyne Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Dyne Therapeutics?
El último beneficio anual de Dyne Therapeutics es USD -235.94M
¿Cuál es la dirección registrada de Dyne Therapeutics?
La dirección registrada de Dyne Therapeutics es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Dyne Therapeutics?
La dirección del sitio web de Dyne Therapeutics es www.dyne-tx.com
¿En qué sector industrial opera Dyne Therapeutics?
Dyne Therapeutics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
INTZIntrusion Inc
US$ 2.167
(381.56%)
189.59M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
HUBCWHub Cyber Security Ltd
US$ 0.035
(250.00%)
2.79M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.94M
LITMSnow Lake Resources Ltd
US$ 1.61
(82.95%)
131.96M
NEUPNeuphoria Therapeutics Inc
US$ 4.11
(-92.30%)
940.73k
VIRXViracta Therapeutics Inc
US$ 0.16
(-32.49%)
9.47M
PRFXPainReform Ltd
US$ 3.48
(-28.98%)
949.52k
AIREreAlpha Tech Corporation
US$ 2.56
(-28.49%)
8.42M
AVGRAvinger Inc
US$ 0.9721
(-24.05%)
2.16M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.94M
RGTIRigetti Computing Inc
US$ 17.08
(10.62%)
305.78M
XTIAXTI Aerospace Inc
US$ 0.03935
(-1.63%)
267.99M
QSIQuantum Si Inc
US$ 3.585
(66.74%)
256.01M

Discusión

Ver feed completo
snoopycomic snoopycomic 2 minutos hace
His original posting is available on Telegram. Far fetched idea -100% speculation. Posted at 12:24 PM today. Different handle ofcourse. 
NWBO
Eli's Gone Eli's Gone 3 minutos hace
This is the longest break in about a decade---I might have to learn how to spell Scheffler again...
attilathehunt attilathehunt 5 minutos hace
Briefly, Magistrate is writing a potentially seminal ruling

I could see that. Jump on the band wagon to fight the manipulation while making name for yourself.

It would be a welcome development!
NWBO
getmoreshares getmoreshares 5 minutos hace
looks like one person-- and a tax sale.--- vol all at once.
CGAC
gitreal gitreal 5 minutos hace
Rich, he is currently promoting a mine with supposed rhodium at levels never seen before anywhere, anytime. That's not in the past, not in the future. Now, it's his current promotion.

There is no copper in the Mt. Vernon ores, so your comment about copper is irrelevant.
NBRI
TheSprinx TheSprinx 6 minutos hace
Check this out

http://www.xchain.cz/
HMBL
StockItOut StockItOut 6 minutos hace
Is like, a "seasoned building" some shredded Nexboard in a bowl of milk with a glass of Retacell? Like for Breakfast?
XERI
Acme Investments Acme Investments 8 minutos hace
Some people will cut off their nose 👃 to spite their Face!!
KAST
Truth and Transparency Truth and Transparency 9 minutos hace
Would be a complete waste of your time and money. I have no fu@king idea who you, he,she, they, them or anyone else is.

Mark Smith never fails to disappoint

What I do know! I’m down over 70% of my combined share price, much like several other people here. I’m mad as fu
NB
govprs govprs 10 minutos hace
Lol 
RVVTF
lvhd lvhd 10 minutos hace
Nope 
AMD
Paulie Cashews Paulie Cashews 11 minutos hace
I never met a charcuterie board I didn't like. Wish I could say that about iHubbers.

adserv.stocksite.com/images/paulie/chewing.gif

www.investorshub.com/boards/plustrees.asp?board_id=2581 Paulie's Pixel Palace
SSP SSP 11 minutos hace
🤣 lmao!
Catmandoo Catmandoo 11 minutos hace
#8 Breakout Boards..keep up the good work..bashers getting us lots of exposure with their non-sense posts.
HMBL
price_and_volume price_and_volume 12 minutos hace
Eisenhower might take exception to that..
I only know two words in french - Omle du framage, and surrender. He repeatedly stated D-Day would have been a failure & the allies wouldn't have won WWII w/o French Resistance. There are many books on the subject of course.

Nvm the St
HMBL
Researchfyi Researchfyi 13 minutos hace
Another week passes and LQMT’s share price is up 1.95% from 0.0412 cents to 0.042 cents on extremely weak trading volumes and little interest. The same when LQMT moves up or down.

Perhaps in 2025 or 2026 LQMT might succeed and if they ever do make it, all in it will be very thankful
LQMT
SSP SSP 14 minutos hace
The late Jim Bishop said this "Don't chase it up. Get it, when it drops back, simply because, THEY ALWAYS DROP BACK, they HAVE to, it is just part of the mechanics of the market maker system, and of course, the inevitable profit taking, and if you aren't taking profits relentlessly, then what the he
ATOM
georgejjl georgejjl 14 minutos hace
Short-Squeeze Target Anavex Life Sciences Gains Traction

https://www.marketbeat.com/originals/short-squeeze-target-anavex-life-sciences-gains-traction/

Good luck and GOD bless,
AVXL
cojoboy cojoboy 15 minutos hace
The question is..what do we know..or what do they know.??..🤔🤔🤔🤔
CGAC
MasterBlastr MasterBlastr 15 minutos hace
So it's making a difference, or not?
AMC
jimmy051357 jimmy051357 15 minutos hace
T - 2 days
SANP
Smartypants2 Smartypants2 16 minutos hace
Apparently you never heard of Dave Zajac, XERI's Managing Director, Advanced Chemicals and Materials...
David Zajac has over 40 years of experience as a seasoned building materials executive. Over his distinguished career, he has held leadership positions with a number of international corpor
PPG XERI
Chiugray Chiugray 17 minutos hace
Pilgrim, All standard as I believe this securities prospectus is related to the $50M financing facility.

8K:
"The Company and Yorkville also entered into a standby equity subscription agreement (the “Subscription Agreement”) which the Company may use after the Note is repaid o
NWBO
Zorax Zorax 18 minutos hace
I don't think so. Because a vast majority are too stupid and they will love everything the gop does because it hurts the libs. They're too stupid to look around themselves.
The maga stupids will just sit in their slowly boiling pots til it's so hot they'll pass out and drown.

I
STL Stock STL Stock 18 minutos hace
When one believes something bad enough they will twist or have a play on words to fit their narrative. Both bulls and bears are guilty of this. They can both help or screw you. I've seen bears swear and promise doom and gloom only to see share prices sky rocket in their face. Likewise I've seen bull
HMBL

Su Consulta Reciente

NASDAQ
DYN
Dyne Therapeutics
USOTC
AAVXF
Abivax (PK)
BIT
W7B980
Unicredit Bank
BIT
SSL
SS Lazio
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados